[HTML][HTML] Severe hospital events following symptomatic infection with SARS-CoV-2 Omicron and Delta variants in France, December 2021–January 2022: a …
…, Y Le Strat, J Schaeffer, L Fournier, C Tamandjou… - …, 2022 - thelancet.com
Background A rapid increase in incidence of the SARS-CoV-2 Omicron variant (sub-lineage
BA.1) occurred in France in December 2021, while the Delta variant was prevailing since …
BA.1) occurred in France in December 2021, while the Delta variant was prevailing since …
[HTML][HTML] Effectiveness of second booster compared to first booster and protection conferred by previous SARS-CoV-2 infection against symptomatic Omicron BA. 2 and …
C Tamandjou, V Auvigne, J Schaeffer, S Vaux… - Vaccine, 2023 - Elsevier
In face of evidence of rapid waning of vaccine effectiveness against Omicron and its sub-lineages,
a second booster with mRNA vaccines was recommended for the most vulnerable in …
a second booster with mRNA vaccines was recommended for the most vulnerable in …
[HTML][HTML] Viral hepatitis associated hepatocellular carcinoma on the African continent, the past, present, and future: a systematic review
OB Dakurah, CRT Tamandjou, M Zunza, W Preiser… - BMC cancer, 2021 - Springer
Background Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related
deaths in Africa. In Africa, the major causes of HCC include chronic infection with hepatitis B …
deaths in Africa. In Africa, the major causes of HCC include chronic infection with hepatitis B …
[HTML][HTML] Is hepatitis B birth dose vaccine needed in Africa?
CR Tamandjou, TG Maponga, N Chotun… - The Pan African …, 2017 - ncbi.nlm.nih.gov
This commentary describes the need for a birth dose monovalent hepatitis B virus (HBV)
vaccine and an effective programme for the prevention of mother-to-child-transmission (MTCT) …
vaccine and an effective programme for the prevention of mother-to-child-transmission (MTCT) …
Protection against symptomatic SARS-CoV-2 BA. 5 infection conferred by the Pfizer-BioNTech Original/BA. 4-5 bivalent vaccine compared to the mRNA Original …
V Auvigne, C Tamandjou, J Schaeffer, S Vaux… - medRxiv, 2023 - medrxiv.org
This cohort study aimed to evaluate the protection against symptomatic SARS-CoV-2 infection
conferred by the Pfizer-BioNTech Original/BA.4-5 bivalent vaccine compared to mRNA …
conferred by the Pfizer-BioNTech Original/BA.4-5 bivalent vaccine compared to mRNA …
[HTML][HTML] Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa
J Mokaya, EAO Burn, CR Tamandjou, D Goedhals… - BMC Public Health, 2019 - Springer
Background International sustainable development goals for the elimination of viral hepatitis
as a public health problem by 2030 highlight the need to optimize strategies for prevention, …
as a public health problem by 2030 highlight the need to optimize strategies for prevention, …
[HTML][HTML] Equity for excellence in academic institutions: a manifesto for change
…, A Noé, J Mokaya, C Tamandjou… - Wellcome Open …, 2021 - ncbi.nlm.nih.gov
Higher academic institutions in the UK need to drive improvements in equity, diversity, and
inclusion (EDI) through sustainable practical interventions. A broad view of inclusivity is …
inclusion (EDI) through sustainable practical interventions. A broad view of inclusivity is …
[HTML][HTML] Impact of vaccination against severe COVID-19 in the French population aged 50 years and above: a retrospective population-based study
L Tan-Lhernould, C Tamandjou, G Deschamps… - BMC medicine, 2023 - Springer
Background Given the widespread implementation of COVID-19 vaccination to mitigate the
pandemic from the end of 2020, it is important to retrospectively evaluate its impact, in …
pandemic from the end of 2020, it is important to retrospectively evaluate its impact, in …
[PDF][PDF] FOCUS//Focus
C Tamandjou, S Laporal, F Lot… - SOMMAIRE … - beh.santepubliquefrance.fr
La surveillance épidémiologique des infections par les virus des hépatites C (VHC), B (VHB)
et Delta (VHD), réalisée par Santé publique France, repose sur plusieurs systèmes …
et Delta (VHD), réalisée par Santé publique France, repose sur plusieurs systèmes …
[PDF][PDF] Viral hepatitis associated hepatocellular carcinoma on the African continent, the past, present, and future: a systematic
OB Dakurah, CRT Tamandjou, M Zunza, W Preiser… - 2021 - bmccancer.biomedcentral.com
Background: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related
deaths in Africa. In Africa, the major causes of HCC include chronic infection with hepatitis …
deaths in Africa. In Africa, the major causes of HCC include chronic infection with hepatitis …
